Name: 欧洲睡眠障碍治疗市场 – 行业趋势和 2028 年预测
Brand: Data Bridge Market Research
SKU: 59667
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

>欧洲睡眠障碍治疗市场，按类型（失眠、睡眠呼吸暂停、不宁腿综合征 (RLS)、发作性睡病等）、治疗（药物治疗、机械治疗、下颌推进装置、舌下神经刺激器、手术等）、给药途径（口服、肠外和其他）、药物类型（品牌和仿制药）、人群类型（儿童和成人）、最终用户（医院、专科诊所、家庭医疗保健、门诊手术中心和其他）、分销渠道（直接招标、医院药房、零售药房、网上药房和其他）、国家（英国、德国、法国、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、土耳其、西班牙、意大利、荷兰、瑞士、俄罗斯和欧洲其他地区）划分，行业趋势和预测到 2028 年

市场分析与洞察：欧洲睡眠障碍治疗市场

睡眠障碍治疗市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场将以 7.6% 的复合年增长率增长，预计到 2028 年将达到 28.4903 亿美元。由于全球睡眠呼吸暂停、失眠和嗜睡症等睡眠障碍的患病率增加，欧洲睡眠障碍治疗市场预计将增长。

睡眠障碍，例如睡眠呼吸暂停、嗜睡症或失眠症，是一种医学障碍，患者难以维持睡眠或入睡。这种疾病会导致精神、身体、社交和情绪功能紊乱。根据患者的症状，睡眠障碍可通过不同的治疗方法进行治疗。大多数睡眠呼吸暂停患者通过机械疗法进行治疗。

睡眠障碍的增加将增加对睡眠障碍治疗方案的需求。因此，由于忙碌的生活和不良习惯而导致的精神压力增加预计将推动睡眠障碍治疗市场的增长。副作用的程度可能危及生命，导致患者对消费产生恐惧，从而导致销售和需求下降。因此，药物的不良反应是睡眠障碍治疗市场增长的制约因素。技术进步的不断进步为促进睡眠障碍治疗市场的需求提供了机会。睡眠障碍治疗的高成本对睡眠障碍治疗市场的增长构成了挑战。

The sleep disorder treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the sleep disorder treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Sleep Disorder Treatment Market Scope and Market Size

The sleep disorder treatment market is categorized into seven notable segments which are based on the type, treatment, route of administration, drugs type, population type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of type, the sleep disorder treatment market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS), narcolepsy and others. In 2021, insomnia segment is expected to dominate the sleep disorder treatment market because of the technological advancement in order to develop innovative treatment options for the particular disorder.
On the basis of treatment, the sleep disorder treatment market is segmented into pharmacological therapy, mechanical therapy, mandibular advancement devices, hypoglossal nerve stimulator, surgery and others. In 2021, pharmacological therapy segment is expected to dominate the sleep disorder treatment market because numerous classes of medications are available for the treatment of sleep disorder as per the symptoms of patients.
On the basis of route of administration, the sleep disorder treatment market is segmented into oral, parenteral and others. In 2021, oral segment is expected to dominate the sleep disorder treatment market because of the increased availability of oral drugs for the treatment of sleep disorders like narcolepsy, restless legs syndrome (RLS) and insomnia among others.
On the basis of drugs type, the sleep disorder treatment market is segmented into branded and generics. In 2021, generics segment is expected to dominate the sleep disorder treatment market because of the increased availability of generic drugs for the treatment of sleep disorders such as Gabapentin, Zolpidem ER Tablets and Eszopiclone Tablets, CIV among others.
On the basis of population type, the sleep disorder treatment market is segmented into children and adults. In 2021, adults segment is expected to dominate the sleep disorder treatment market due to the surging geriatric population across globe requiring more advanced treatment options.
根据最终用户，睡眠障碍治疗市场分为医院、专科诊所、家庭医疗保健、门诊手术中心和其他。2021 年，医院部门预计将主导睡眠障碍治疗市场，因为医院有财力购买手术中使用的昂贵设备，并且有训练有素的专业人员操作机械设备和处方药。
根据分销渠道，睡眠障碍治疗市场分为直接招标、医院药房、零售药房、网上药房和其他。2021 年，直接招标市场预计将主导睡眠障碍治疗市场，因为大多数药品都是通过直接招标服务采购的。

睡眠障碍治疗市场国家层面分析

对睡眠障碍治疗市场进行分析，并按上述国家、类型、治疗、给药途径、药物类型、人口类型、最终用户和分销渠道提供市场规模信息。

欧洲睡眠障碍治疗市场报告涵盖的国家包括英国、德国、法国、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、土耳其、西班牙、意大利、荷兰、瑞士、俄罗斯和欧洲其他地区。

在欧洲睡眠障碍治疗市场，德国占据主导地位，因为睡眠障碍患病率不断上升，而且该国老年人口的不断增长也扩大了睡眠障碍治疗市场。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

制造商推出的新产品为睡眠障碍治疗市场参与者创造了新的机会

睡眠障碍治疗市场还为您提供了每个国家美容行业增长的详细市场分析，包括睡眠障碍治疗市场的销售、睡眠障碍治疗市场发展的影响以及监管环境的变化及其对睡眠障碍治疗市场的支持。数据涵盖 2010 年至 2019 年的历史时期。

竞争格局和睡眠障碍治疗市场份额分析

睡眠障碍治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对睡眠障碍治疗市场的关注有关。

报告中涵盖的睡眠障碍治疗市场的主要参与者包括 Jazz Pharmaceuticals, Inc.、Pfizer Inc.、Viatris Inc.、Hikma Pharmaceuticals PLC、Amneal Pharmaceuticals LLC.、Taj Pharmaceuticals Limited、Eli Lilly and Company、Mallinckrodt、Alembic Pharmaceuticals Limited、Dr. Reddy's Laboratories Ltd.、Taro Pharmaceutical Industries Ltd.、Koninklijke Philips NV、DeVilbiss Healthcare LLC、ResMed 和 SomnoMed 等国内参与者。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也推出了许多产品并达成了多项协议，这也加速了睡眠障碍治疗市场的发展。

例如，

2019 年 11 月，辉瑞公司宣布其 Upjohn 部门与 Mylan NV 合并，成立了一家名为 Viatris 的新公司。该公司业务部门与 Mylan NV 的合并扩大了其产品组合，从而增加了市场对其产品的需求。

市场参与者的合作、合资和其他策略正在增强公司在睡眠障碍治疗市场中的市场，这也为组织改善其睡眠障碍治疗服务提供了好处。

SKU-59667

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

LIST OF TABLES

TABLE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT

TABLE 3 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 4 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 5 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 6 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 7 EUROPE SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 8 EUROPE RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 9 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 10 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 11 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)

TABLE 12 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 13 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 14 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 15 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 16 EUROPE MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 17 EUROPE HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 18 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 20 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 21 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 22 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 23 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 24 EUROPE PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 25 EUROPE OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 26 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 27 EUROPE GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 28 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 29 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 30 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)

TABLE 31 EUROPE ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 32 EUROPE CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 33 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)

TABLE 34 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 35 EUROPE SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 36 EUROPE HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 37 EUROPE AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 38 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 39 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)

TABLE 40 EUROPE DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 41 EUROPE HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 42 EUROPE RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 43 EUROPE ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 44 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 45 EUROPE SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 46 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 49 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 50 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 51 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 52 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 53 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 54 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 55 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 56 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 57 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 58 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 59 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 60 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 61 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 GERMANY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 GERMANY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 64 GERMANY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 65 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 66 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 67 GERMANY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 68 GERMANY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 69 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 70 GERMANY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 71 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 72 GERMANY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 73 GERMANY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 74 GERMANY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 75 GERMANY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 76 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 FRANCE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 FRANCE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 79 FRANCE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 80 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 81 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 82 FRANCE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 83 FRANCE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 84 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 85 FRANCE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 86 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 87 FRANCE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 88 FRANCE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 89 FRANCE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 90 FRANCE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 91 U.K. SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 U.K. INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 U.K. SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 94 U.K. NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 95 U.K. SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 96 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 97 U.K. MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 98 U.K. SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 99 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 100 U.K. ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 101 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 102 U.K. BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 103 U.K. SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 104 U.K. SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 105 U.K. SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 106 ITALY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ITALY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 ITALY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 109 ITALY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 110 ITALY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 111 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 112 ITALY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 113 ITALY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 114 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 115 ITALY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 116 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 117 ITALY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 118 ITALY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 119 ITALY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 120 ITALY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 121 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 SPAIN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 123 SPAIN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 124 SPAIN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 125 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 126 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 127 SPAIN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 128 SPAIN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 129 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 130 SPAIN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 131 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 132 SPAIN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 133 SPAIN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 134 SPAIN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 135 SPAIN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 136 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 RUSSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 RUSSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 139 RUSSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 140 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 141 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 142 RUSSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 143 RUSSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 144 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 145 RUSSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 146 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 147 RUSSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 148 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 149 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 150 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 151 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 IRELAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 153 IRELAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 154 IRELAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 155 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 156 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 157 IRELAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 158 IRELAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 159 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 160 IRELAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 161 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 162 IRELAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 163 IRELAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 164 IRELAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 165 IRELAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 166 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 167 NORWAY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 168 NORWAY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 169 NORWAY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 170 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 171 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 172 NORWAY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 173 NORWAY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 174 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 175 NORWAY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 176 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 177 NORWAY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 178 NORWAY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 179 NORWAY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 180 NORWAY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 181 POLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 182 POLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 183 POLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 184 POLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 185 POLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 186 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 187 POLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 188 POLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 189 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 190 POLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 191 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 192 POLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 193 POLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 194 POLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 195 POLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 196 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 TURKEY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 198 TURKEY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 199 TURKEY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 200 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 201 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 202 TURKEY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 203 TURKEY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 204 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 205 TURKEY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 206 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 207 TURKEY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 208 TURKEY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 209 TURKEY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 210 TURKEY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 211 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 212 HUNGARY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 213 HUNGARY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 214 HUNGARY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 215 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 216 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 217 HUNGARY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 218 HUNGARY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 219 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 220 HUNGARY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 221 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 222 HUNGARY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 223 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 224 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 225 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 226 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 227 AUSTRIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 228 AUSTRIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 229 AUSTRIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 230 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 231 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 232 AUSTRIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 233 AUSTRIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 234 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 235 AUSTRIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 236 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 237 AUSTRIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 238 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 239 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 240 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 241 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 242 LITHUANIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 243 LITHUANIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 244 LITHUANIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 245 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 246 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 247 LITHUANIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 248 LITHUANIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 249 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 250 LITHUANIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 251 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 252 LITHUANIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 253 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 254 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 255 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 256 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 257 NETHERLANDS INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 258 NETHERLANDS SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 259 NETHERLANDS NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 260 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 261 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 262 NETHERLANDS MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 263 NETHERLANDS SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 264 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 265 NETHERLANDS ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 266 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 267 NETHERLANDS BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 268 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 269 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 270 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 271 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 272 SWITZERLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 273 SWITZERLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 274 SWITZERLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 275 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 276 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 277 SWITZERLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 278 SWITZERLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 279 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 280 SWITZERLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 281 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 282 SWITZERLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 283 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 284 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 285 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 286 REST OF EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

图片列表

LIST OF FIGURES

FIGURE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE SLEEP DISORDER TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE EUROPE SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE SLEEP DISORDER TREATMENT MARKET

FIGURE 14 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 15 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 16 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020

FIGURE 17 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 18 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 19 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020

FIGURE 21 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)

FIGURE 22 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)

FIGURE 23 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 24 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 25 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 26 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 27 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 28 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020

FIGURE 29 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)

FIGURE 30 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)

FIGURE 31 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE

FIGURE 32 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020

FIGURE 33 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 34 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)

FIGURE 35 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 36 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020

FIGURE 37 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 38 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 39 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 42 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 43 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 49 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.